Cargando…

The Research Progress in Physiological and Pathological Functions of TRAF4

Tumour necrosis factor receptor-associated factor 4 (TRAF4) is a member of the TRAF protein family, a cytoplasmic bridging molecule closely associated with various immune functions. The physiological processes of TRAF4 are mainly involved in embryonic development, cell polarity, cell proliferation,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruan, Xueqin, Zhang, Rong, Li, Ruijuan, Zhu, Hongkai, Wang, Zhihua, Wang, Canfei, Cheng, Zhao, Peng, Hongling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885719/ https://www.ncbi.nlm.nih.gov/pubmed/35242717 http://dx.doi.org/10.3389/fonc.2022.842072

Ejemplares similares

BP‑1‑102 exerts antitumor effects on T‑cell acute lymphoblastic leukemia cells by suppressing the JAK2/STAT3/c‑Myc signaling pathway
por: Ye, Can, et al.
Publicado: (2023)

TRAF3IP3 promotes glioma progression through the ERK signaling pathway
por: Lin, Qi, et al.
Publicado: (2022)

TRAF3: A novel regulator of mitochondrial physiology and metabolic pathways in B lymphocytes
por: Jung, Jaeyong, et al.
Publicado: (2023)

Different Activation of TRAF4 and TRAF6 in Inflammatory Bowel Disease
por: Shen, Jun, et al.
Publicado: (2013)

Targeting TRAF3IP2 inhibits angiogenesis in glioblastoma
por: Izadpanah, Amin, et al.
Publicado: (2022)

TRAF4 Inhibits the Apoptosis and Promotes the Proliferation of Breast Cancer Cells by Inhibiting the Ubiquitination of Spindle Assembly-Associated Protein Eg5
por: Hao, Miaomiao, et al.
Publicado: (2022)

TRAF2 Mediates Physiological Mitophagy
por: Sadoshima, Junichi
Publicado: (2022)

Research Progress of Sirtuin4 in Cancer
por: Bai, Yibing, et al.
Publicado: (2021)

Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma
por: Xing, Cheng, et al.
Publicado: (2023)

Computational Analysis of Pathological Image Enables Interpretable Prediction for Microsatellite Instability
por: Zhu, Jin, et al.
Publicado: (2022)

Variation in Plasma Levels of TRAF2 Protein During Development of Squamous Cell Carcinoma of the Oral Tongue
por: Gu, Xiaolian, et al.
Publicado: (2021)

Biological functions and research progress of eIF4E
por: Chen, Xiaocong, et al.
Publicado: (2023)

The Alteration of T-Cell Heterogeneity and PD-L1 Colocalization During dMMR Colorectal Cancer Progression Defined by Multiplex Immunohistochemistry
por: Yan, Hongkai, et al.
Publicado: (2022)

Research Progress for RNA Modifications in Physiological and Pathological Angiogenesis
por: Chen, Hui-Ming, et al.
Publicado: (2022)

miR-146b-5p promotes colorectal cancer progression by targeting TRAF6
por: Shi, Liangpan, et al.
Publicado: (2022)

PKM2 Is the Target of a Multi-Herb-Combined Decoction During the Inhibition of Gastric Cancer Progression
por: Sun, Qingmin, et al.
Publicado: (2021)

Research Progress of DUB Enzyme in Hepatocellular Carcinoma
por: Zhao, Jie, et al.
Publicado: (2022)

Computed Tomography Radiomics for Predicting Pathological Grade of Renal Cell Carcinoma
por: Yi, Xiaoping, et al.
Publicado: (2021)

Up-regulation and Pre-activation of TRAF3 and TRAF5 in Inflammatory Bowel Disease
por: Shen, Jun, et al.
Publicado: (2013)

Novel Findings in Teleost TRAF4, a Protein Acts as an Enhancer in TRIF and TRAF6 Mediated Antiviral and Inflammatory Signaling
por: Chen, Ying, et al.
Publicado: (2022)

INPP4B inhibits glioma cell proliferation and immune escape via inhibition of the PI3K/AKT signaling pathway
por: Sun, Xiaoming, et al.
Publicado: (2022)

Recent research and clinical progress of CTLA-4-based immunotherapy for breast cancer
por: Zhang, Hongsheng, et al.
Publicado: (2023)

Physiological and Pathological Researches
Publicado: (1837)

The Effects of TRAF6 on Growth and Progression in Colorectal Cancer are Regulated by miRNA-140
por: Zhu, Guangwei, et al.
Publicado: (2020)

Research progress of Claudin-low breast cancer
por: Pan, Chenglong, et al.
Publicado: (2023)

Research Progress of Pancreas-Related Microorganisms and Pancreatic Cancer
por: Zhang, Wenqing, et al.
Publicado: (2021)

TRAF4 Inhibits Bladder Cancer Progression by Promoting BMP/SMAD Signaling
por: Iyengar, Prasanna Vasudevan, et al.
Publicado: (2022)

Research progress on molecular biomarkers of acute myeloid leukemia
por: Yin, Pei-Yuan, et al.
Publicado: (2023)

Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy
por: Zhang, Wenxiang, et al.
Publicado: (2021)

Brief Research Report Regional Difference in TRAF2 and TRAF3 Gene Mutations in Colon Cancers
por: Moon, Seong Won, et al.
Publicado: (2021)

Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research
por: Wu, Shilun, et al.
Publicado: (2022)

Immunometabolism in the tumor microenvironment and its related research progress
por: Zhang, Ziheng, et al.
Publicado: (2022)

Research progress on the application of optical coherence tomography in the field of oncology
por: Yang, Linhai, et al.
Publicado: (2022)

Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
por: Xie, Shuqi, et al.
Publicado: (2023)

Research Progress of circRNAs in Head and Neck Cancers
por: Li, Panchun, et al.
Publicado: (2021)

Editorial: Research progress on immune microenvironment and molecular mechanism of glioma
por: Marei, Hany E., et al.
Publicado: (2023)

Immune infiltration and drug specificity analysis of different subtypes based on functional status in angioimmunoblastic T-cell lymphoma
por: Zhu, Shicong, et al.
Publicado: (2023)

The Contribution of Physiological and Accelerated Aging to Cancer Progression Through Senescence-Induced Inflammation
por: Morales-Valencia, Jorge, et al.
Publicado: (2021)

Research Progress on Circular RNA in Glioma
por: Chen, Mengyu, et al.
Publicado: (2021)

Research Progress of Bile Acids in Cancer
por: Fu, Junhao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_59h95mmepsqr5i4e6no9n1tp4j